http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-102015004857-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3f6e65f99ee78e949ad7bd6d2175243d |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 |
| filingDate | 2015-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_076ac4f8d3aedac2ed765ff843ab8f92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cedd19c4b0428c48ea4b830fb7f5e56 |
| publicationDate | 2016-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-102015004857-A2 |
| titleOfInvention | Process for the preparation of imatinib and imatinib mesylate non-needle alpha-2 form |
| abstract | "process for the preparation of imatinib and imatinib mesylate non-needle alpha2 form." the present invention relates to an efficient and industrially viable process for the preparation of imatinib and imatinib mesylate non-needle ?2 form imatinib in high purity, without requiring purification by recrystallization or column chromatography. the process of the present invention is easy, fast and economical, where imatinib mesylate is obtained in high yield and purity. 1/1 |
| priorityDate | 2015-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 53.